P21 Peptide in Canada
P21 is a short lab-made peptide based on CNTF, a growth factor the nervous system uses. It carries an adamantane cage, a stiff carbon structure added to help it get into the brain. It was developed in New York, and its research so far is in lab models of Alzheimer's disease. It has never been studied in people or approved as a drug.

Pack prices and discount codes don't combine. You always get the bigger saving.
Sold for laboratory research use only. Not for human or veterinary use. 19+.
- Amino acids plus an adamantane unit at the end
- 4 + 1
- Molar mass
- 578.7g/mol
- Parent protein, ciliary neurotrophic factor
- CNTF
- Human trials, registered or published
- 0
- Approved as a drug
- Nowhere
- Free over $250 Shipping $20 to $25 under that
- Interac e-Transfer Confirms in ~30 min
- 14-day returns Free return shipping
- Third-party tested Janoshik Analytical results below
- Ships cold Paid by noon, ships same day
- Mixing calculator Get your volumes
What is P21?
The plain-language version, first.
A neurotrophin fragment wearing a chemical crash helmet.
The parent story matters here, because P21 exists to fix the parent's specific failure.
CNTF is a growth factor your nervous system uses. It went into development decades ago, and it ran into problems including immune reactions and a molecule too large and fragile to deliver well.
P21 is a small fragment derived from it, wearing an adamantane group, which is a rigid carbon cage bolted on so the fragment can cross the blood-brain barrier.
Adamantane is a real trick with real precedent. Several approved drugs use that cage for exactly this purpose.
So the design reads sensibly: keep a working piece, armour it, get it into the brain by mouth.
A rational repair job on a failed molecule. The design is the strong part of this file.
What is P21 peptide?
What researchers watch it do.
The parent molecule failed for a fixable reason, and this is the attempted fix.
The proposed mechanism sits in an interesting corner of brain biology: the birth of new neurons.
The lab work points at P21 nudging neural progenitor cells toward becoming neurons, partly by interfering with a signal called LIF that normally holds them back.
Releasing a handbrake rather than pressing an accelerator. As mechanisms go it is a genuinely elegant one.
It is also, so far, a lab mechanism. The models used are dementia models, the durations run long for lab work, and the oral activity claim has held up in that setting.
Here's the honest part, in the plainest terms available.
No human has taken this compound in any registered trial. The entire file lives in the lab, and elegance in the lab is still the lab.
What does the research say about P21?
What the studies found, and where they stand.
Lab work with an interesting shape, and a human column that is empty.
The animal file has a specific strength worth naming: duration.
Lab studies have run up to eighteen months, which is long for this kind of work, without the toxicity pattern that helped sink the parent molecule.
Long, clean animal runs are genuinely encouraging. They are also exactly where every failed neurology drug looked good, because the brain is where animal models betray you most.
Neurology has the worst translation rate in all of drug development. Compounds that looked great in lab models of dementia are a crowded graveyard.
No human trials. Nothing approved. No safety data in people at all.
A well-designed molecule with promising lab work, standing at the exact spot where hundreds of promising molecules have previously fallen over. Respect the design. Price in the graveyard.
P21 peptide, research grade, sold for laboratory use only.
What did the lab find in our P21?
2 sizes, one lot each, the lab's numbers for every one.
2 mgLot 2216-35699.16%2.06 mgOpenClose
5 mgLot 2218-80898.88%5.21 mgOpenClose
What's in a vial of P21?
The chemistry, exactly as released.
Who studies P21?
Who tends to order this one, and why.
- 1
Groups working on oral peptide delivery
The adamantane cage is a concrete, reproducible answer to the blood brain barrier problem, and the feed-dosed study is the proof point.
- 2
Tau and amyloid model labs
The 3xTg-AD readouts in the Kazim work cover tau phosphorylation and soluble amyloid beta in the same animals, which is a convenient combined endpoint set.
- 3
Neurogenesis researchers
The LIF inhibition mechanism is an unusual route to progenitor differentiation and is not widely used as a tool approach.
- 4
Anyone confusing this with p21 the protein
P021 the peptide and p21 the cyclin-dependent kinase inhibitor share nothing but a label. Literature searches on the bare term return mostly the protein.
Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.
Where did P21 come from?
How it got here.
The New York State Institute for Basic Research sits on Staten Island, which is not where anybody expects Alzheimer's chemistry to come from. Khalid Iqbal's group there has been working on tau for a very long time.
The idea behind P021 is almost stubborn. CNTF failed in humans for reasons that had nothing to do with whether it helped neurons. It failed because the whole protein did too many things at once and some of them were awful. So rather than declare the target dead, they asked which small piece carried the useful signal.
Then they solved the delivery problem with an adamantane cage, which is a genuinely elegant piece of medicinal chemistry dressed up as brute force. And then they proved the point in the least glamorous way available. They put it in the feed and left it there for a year.
- 1
CNTF's bad trial
Ciliary neurotrophic factor went into ALS trials and produced anorexia, muscle pain and cramps. The protein was effectively shelved as a systemic therapeutic.
- 2
Staten Island, not Cambridge
Khalid Iqbal's lab at the New York State Institute for Basic Research took a short region of CNTF and built a peptide around it rather than abandoning the target.
- 3
Dosed in the chow
The pivotal twelve month 3xTg-AD study administered P021 in the feed. An orally active neuroactive peptide is rare enough that this is the headline detail.
How do I buy P21 in Canada?
What ships, how fast, and the paperwork.
Research use only. Sold for laboratory research use only, not for human or veterinary consumption. Health Canada's advisory of 9 April 2026 states that peptides are generally regulated as prescription drugs in Canada, and that "For Research Use Only" labelling does not make these products legal. P21 is not named in that advisory, which is not the same as being cleared.
No CAS number, on purpose. We could not locate a CAS registry number for P021 in any primary source. Some listings print one anyway. A blank you can trust beats a number you can't.
Two molecular weights in circulation. PubChem CID 56589645 gives 578.7. A second source gives 578.3. They agree to within 0.4 daltons and both describe the same compound, C27H42N6O8.
What else do people ask?
5 answers, none of them dodges.
Is P21 the same as the p21 protein?
No, and the name collision causes real confusion. p21, also called Cip1 or Waf1, is a cyclin-dependent kinase inhibitor involved in the cell cycle. P021 is a small synthetic peptide derived from ciliary neurotrophic factor, written Ac-DGGL(A)G-NH2. They're unrelated. If you search the bare term in a literature database, most of what comes back is the protein rather than the peptide.
What is the adamantane group for?
Brain access. P021 is a small water-loving peptide, and the blood brain barrier is built to keep those out. Attaching a rigid adamantane cage to the C-terminal glycine makes the molecule fat-soluble enough to cross. It's the modification that turns an otherwise ordinary CNTF fragment into something that works by mouth in lab models.
Is P021 really orally active?
In lab models, yes, and that's the most distinctive thing about it. The pivotal twelve month study in an Alzheimer's lab model put P021 in the feed (Kazim, 2014, PMID 25046994). Oral activity is uncommon for neuroactive peptides. Whether it carries into any other species is unknown, because no other species has been tested.
Why was P021 made if CNTF already existed?
Because CNTF failed people. In ALS trials the full-length protein caused anorexia, muscle pain and cramps, which made it unusable systemically no matter what it did for neurons. Khalid Iqbal's lab kept the short region that carried the useful signal and dropped the rest. In lab studies running up to eighteen months, P021 didn't produce weight loss or signs of pain.
What did the lab studies actually report?
Chronic oral P021 in an Alzheimer's lab model reduced tau hyperphosphorylation and soluble amyloid beta, increased BDNF, and in the authors' words rescued deficits in cognition, neurogenesis and synaptic plasticity (Kazim, 2014, Neurobiology of Disease). Those are model-system endpoints in a genetically engineered lab model, which is a long way from a clinical outcome in a person.
P21 Peptide vs Dihexa: what's the difference?
Stacked together constantly, compared almost never.
The two brain-penetrant hopefuls of this catalogue, and the difference between their files is a lesson in how evidence ages.
P21 is a rationally designed CNTF fragment in an adamantane cage, with long-duration lab work and zero human subjects ever. Its file is thin but intact.
Dihexa had a bigger reputation and then three of its foundational papers were retracted in 2025, leaving one independent lab study upright.
A small file that holds beats a large one that had to be taken back. Neither has touched a human, and the lab-to-human gap in neurology is the widest in all of drug development. Dihexa has its own page here
What pairs well with P21?
What researchers stack alongside it.
Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as P21 Peptide, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

A tiny lab-made protein built in Moscow from one chopped-off piece of a stress hormone, and sold in Russian pharmacies as nose drops. Scientists study it on stroke and on BDNF, which is basically plant food for your nerve cells.
Supplies for the lab
What else is in Neural?
Other compounds in the same research category.
Ready to order P21?
One last look before you decide.
Freeze-dried, lab results on the page, ships cold
You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, P21 is right here.
Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.
Page last updated November 12, 2026. Reviewed by the Pro Peptide team.
What do people search for with P21?
Related searches.


